Abstract
Introduction: CAC-RADS and CAD-RADS were introduced to create a standardized method to communicate findings of coronary calcium scoring (CCS) and coronary CT angiography (cCTA) and to facilitate standardized clinical decision making regarding the potential need of further assessment and management. Yet an important and welcome “by-product” may be the ability to respectively quantitate and semi-quantitate the extent and/or severity of disease biomarkers in large distinct patient groups and population. For example, characterisation of the UK NICE-CG95 compliant RACPAC populations, as underway in the National audit CA2017-18-191, has the potential to yield extremely valuable information on disease distribution and hot-spots allowing the creation of “disease heat maps” which in turn can be used to inform public health and research strategies alike as well as informing and ultimately optimising down-stream resource utilisation.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call